CoChat

Molecular mechanisms of retroviral integrase inhibition and the evolution of viral resistance

Open access
Hare, Stephen, Vos, Ann M., Clayton, Reginald F., Thuring, Jan W., Cummings, Maxwell D., Cherepanov, Peter · 2010 · Proceedings of the National Academy of Sciences

The DOI matches its Crossref record; 42 of the 45 references it cites were found in a registry or an index.

Abstract

The development of HIV integrase (IN) strand transfer inhibitors (INSTIs) and our understanding of viral resistance to these molecules have been hampered by a paucity of available structural data. We recently reported cocrystal structures of the prototype foamy virus (PFV) intasome with raltegravir and elvitegravir, establishing the general INSTI binding mode. We now present an expanded set of cocrystal structures containing PFV intasomes complexed with first- and second-generation INSTIs at resolutions of up to 2.5 Å. Importantly, the improved resolution allowed us to refine the complete coordination spheres of the catalytic metal cations within the INSTI-bound intasome active site. We show that like the Q148H/G140S and N155H HIV-1 IN variants, the analogous S217H and N224H PFV INs display reduced sensitivity to raltegravir in vitro. Crystal structures of the mutant PFV intasomes in INSTI-free and -bound forms revealed that the amino acid substitutions necessitate considerable conformational rearrangements within the IN active site to accommodate an INSTI, thus explaining their adverse effects on raltegravir antiviral activity. Furthermore, our structures predict physical proximity and an interaction between HIV-1 IN mutant residues His148 and Ser/Ala140, rationalizing the coevolution of Q148H and G140S/A mutations in drug-resistant viral strains.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.1010246107

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 42 references

Research works printed but not linked: 7

  1. R Craigie, Retroviral DNA integration. Mobile DNA II, eds NL Craig, R Craigie, M Gellert, AM Lambowitz (ASM Press, Washington, DC), pp. 613–630 (2002).
  2. J Vacca, et al., Discovery of MK-2048—subtle changes confer unique resistance properties to a series of tricyclic hydroxypyrrole integrase strand transfer inhibitors. Fourth International AIDS Socienty Conference (Sydney, 2007).
  3. D Hazuda, M Miller, B Nguyen, J Zhao, Resistance to the HIV-integrase inhibitor raltegravir: Analysis of protocol 005, a phase II study in patients with triple-class resistant HIV-1 infection. XVI International HIV Drug Resistance Workshop (St Michael, Barbados, 2007).
  4. VA Johnson, et al., Update of the drug resistance mutations in HIV-1: December 2009. Top HIV Med 17, 138–145 (2009).
  5. JA Grobler, K Stillmock, MD Miller, DJ Hazuda, Mechanism by which the HIV integrase active-site mutation N155H confers resistance to raltegravir. Antivir Ther 13, A41 (2008).
  6. JW Evans, et al. Processes and intermediates useful for preparing integrase inhibitor compounds, US Patent Appl US2008/0039487. (2008).
  7. JS Wai, et al., Next generation of inhibitors of HIV-1 integrase strand transfer inhibitor: Structural diversity and resistance profiles. 14th Conference on Retroviruses and Opportunistic Infections (Los Angeles, 2007).

Cited by

See all 329

Metadata

Authors
Hare, S., Vos, A. M., Clayton, R. F., Thuring, J. W., Cummings, M. D., & Cherepanov, P.
Affiliations
  • Imperial College London (GB)
  • Tibotec BVBA, 2340 Beerse, Belgium
Venue
Proceedings of the National Academy of Sciences
Published
2010-10-28
Volume
107
Issue
46
Pages
20057-20062
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2117072114
Cited by
305
References
45
Citations by year
2026: 7 · 2025: 5 · 2024: 11 · 2023: 10 · 2022: 10 · 2021: 27 · 2020: 20 · 2019: 16 · 2018: 13 · 2017: 15 · 2016: 13 · 2015: 26 · 2014: 31 · 2013: 31 · 2012: 38
FWCI
21.36
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • DORA PSI (Paul Scherrer Institute) (submittedVersion)
  • Figshare (submittedVersion)
Topics
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
  • Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
Keywords
HIV integrase, integrase strand transfer inhibitors, drug resistance, raltegravir, elvitegravir, co-crystal structure, conformational change, antiviral activity
MeSH terms
Raltegravir Potassium, Mutation, Pyrrolidinones, Retroviridae, HIV-1, Evolution, Molecular, Integrases, HIV Integrase Inhibitors, Amino Acid Substitution, Inhibitory Concentration 50, Catalytic Domain, Drug Resistance, Viral

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Molecular mechanisms of retroviral integrase inhibition and the evolution of viral resistance. https://app.cochat.ai/papers/10.1073/pnas.1010246107
The paper
Hare, S., Vos, A. M., Clayton, R. F., Thuring, J. W., Cummings, M. D., & Cherepanov, P. (2010). Molecular mechanisms of retroviral integrase inhibition and the evolution of viral resistance. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1010246107

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.